• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Somalogic Inc (NQ: SLGC )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Somalogic Inc

    < Previous 1 2 Next >
    Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting
    From Madryn Asset Management, LP
    Via Business Wire
    Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
    From Madryn Asset Management, LP
    Via Business Wire
    Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
    From Madryn Asset Management, LP
    Via Business Wire
    Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
    Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special Meeting 
    From SomaLogic
    Via GlobeNewswire
    Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
    From SomaLogic
    Via GlobeNewswire
    Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation
    From Madryn Asset Management, LP
    Via Business Wire
    Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools
    From Skye Fund III, LLC
    Via GlobeNewswire
    Madryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
    From Lowey Dannenberg, P.C.
    Via GlobeNewswire
    Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
    From Madryn Asset Management, LP
    Via Business Wire
    Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
    From Lowey Dannenberg, P.C.
    Via GlobeNewswire
    Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
    From Lowey Dannenberg, P.C.
    Via GlobeNewswire
    SomaLogic Reports Recent Business Highlights and Third Quarter 2023 Financial Results
    From SomaLogic
    Via GlobeNewswire
    SomaLogic announces new SomaScan® 11K Platform
    Expanded menu gives researchers broadest coverage of the proteome for increased discovery of biomarkers and drug targets 
    From SomaLogic
    Via GlobeNewswire
    SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023
    From SomaLogic
    Via GlobeNewswire
    SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market
    DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work 
    From SomaLogic
    Via GlobeNewswire
    SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors
    SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types. 
    From SomaLogic
    Via GlobeNewswire
    SomaLogic expands agreement with Novo Nordisk to 2025
    Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases 
    From SomaLogic
    Via GlobeNewswire
    SomaLogic Reports Second Quarter 2023 Financial Results
    From SomaLogic
    Via GlobeNewswire
    SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023
    From SomaLogic
    Via GlobeNewswire
    SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe
    SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe 
    From SomaLogic
    Via GlobeNewswire
    SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
    SomaLogic’s 7,000-plex SomaScan® Platform will be used in clinical research, population health studies and nutrigenomics. 
    From SomaLogic
    Via GlobeNewswire
    SomaLogic Announces Chief Financial Officer Transition
    From SomaLogic
    Via GlobeNewswire
    SomaLogic to Participate in the Jefferies Healthcare Conference
    From SomaLogic
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.